Full-Time

Vice President

Editas Medicine

Editas Medicine

201-500 employees

Clinical stage genome editing for disease treatment

Biotechnology

Expert

Cambridge, MA, USA

Requirements
  • MD or MD/PhD with therapeutically aligned experience
  • 15+ years clinical research experience, with a minimum of ten years in the pharmaceutical/biotechnology industry
  • Demonstrated ability as a line function manager
  • Experience or high comfort level in supporting clinical programs across multiple therapeutic areas, and bridging late to early development, familiarity with gene and/or cell therapy a plus
  • Exposure to and management of significant accelerations and challenges in clinical programs
  • Ability to work with the Senior Executive Team and other external audiences such KOLs, regulatory bodies
Responsibilities
  • Lead clinical development for Editas’ expanding clinical portfolio
  • Lead the strategy, development, and execution of the clinical pipeline
  • Work closely with cross functional drug development teams to define the most effective approach from first-in-human to registrational clinical studies
  • Be a key Editas spokesperson at external meetings, including regulatory interactions and scientific meetings
  • Lead a group of physicians and clinical scientists responsible for conceiving, delivering, and overseeing Phase 1-3 trials
  • Establish plans for long-term follow up and pharmacovigilance
  • Responsible for protocol development and clinical sections of regulatory documents
  • Provide strategic perspective and guidance to Research on decisions that may have significant clinical components and implications
  • Collaborate closely with Non-clinical, Regulatory, Clinical Operations, CMC and Biometrics to ensure tight strategic integration of product development plans and strategies
  • Maintain the highest quality clinical programs, following GCP and ICH guidelines

Editas Medicine stands out as a leader in the field of genomic medicine, leveraging the potential of CRISPR gene editing technology to develop treatments for serious diseases. The company fosters a vibrant culture, encouraging collaboration and resilience among its team of 'Editors', and is committed to manufacturing and commercializing durable, precision genomic medicines. With a robust pipeline of treatments in development, Editas Medicine is not only repairing broken genes but also shaping the future of medicine.

Company Stage

N/A

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

11%

1 year growth

25%

2 year growth

11%